There's an obvious difference here in that I openly admit that I likely erred in citing ongoing P2 trial, in that Vivos has actually expanded the P1 trial in order to evaluate additional Cancers.
Then there is the constant and pathological lies that you post daily and here is yet another example...........
sceeate quote: "They haven't concluded phase 1 yet. 10 patients with neck cancers and so far no reports of Radiogel eliminating treated tumors"
Vivos quote: "Every patient in the trial has met the primary safety endpoint, confirmed through PET imaging showing precise retention of the therapeutic Yttrium-90 isotope at the injection site—with no observed adverse events"
It has been made patently clear, on numerous occasions, that P1 trial primary endpoints are meant to evaluate the Safety of the treatment, NOT its efficacy as you keep foolishly and falsely claiming.
Market Data 
Markets 
AI
